146 related articles for article (PubMed ID: 38086199)
1. Serum ferritin as a significant biomarker for patients with idiopathic inflammatory myopathy-associated interstitial lung disease: A systematic review and meta-analysis.
He X; Ji J; Chen X; Luo Z; Fang S; Yan H; Guo L
Semin Arthritis Rheum; 2024 Feb; 64():152350. PubMed ID: 38086199
[TBL] [Abstract][Full Text] [Related]
2. Different Multivariable Risk Factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis and Anti-Synthetase Syndrome.
Zuo Y; Ye L; Chen F; Shen Y; Lu X; Wang G; Shu X
Front Immunol; 2022; 13():845988. PubMed ID: 35320936
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease: a retrospective study of 679 adult cases.
Li S; Sun Y; Shao C; Huang H; Wang Q; Xu K; Zhang X; Liu P; Zeng X; Xu Z
Rheumatology (Oxford); 2021 Mar; 60(3):1195-1204. PubMed ID: 32894294
[TBL] [Abstract][Full Text] [Related]
4. Multiple values of
Li Y; Zhou Y; Wang Q
Clin Rheumatol; 2017 Oct; 36(10):2297-2305. PubMed ID: 28831580
[TBL] [Abstract][Full Text] [Related]
5. The prognostic role of C-reactive protein to albumin ratio and anti-MDA5 antibody-positive in idiopathic inflammatory myopathy: a retrospective study.
Zhou P; Shen Q; Zhou S; Ouyang X; Guo T; Song M; Guo W; Zhang Y; Peng H
Sci Rep; 2023 Mar; 13(1):3863. PubMed ID: 36890164
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of galectin-3 in idiopathic inflammatory myopathies: a potential biomarker of disease activity.
Watanabe E; Kato K; Gono T; Chiba E; Terai C; Kotake S
Rheumatology (Oxford); 2021 Jan; 60(1):322-332. PubMed ID: 32770187
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.
Laporte A; Mariampillai K; Allenbach Y; Pasi N; Donciu V; Toledano D; Granger B; Benveniste O; Grenier PA; Boussouar S
Eur Radiol; 2022 May; 32(5):3480-3489. PubMed ID: 35022809
[TBL] [Abstract][Full Text] [Related]
8. Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis.
Vojinovic T; Cavazzana I; Ceruti P; Fredi M; Modina D; Berlendis M; Franceschini F
Clin Rev Allergy Immunol; 2021 Feb; 60(1):87-94. PubMed ID: 33141387
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of natural killer cell depletion in predicting progressive fibrosing interstitial lung disease in idiopathic inflammatory myopathies.
Shao C; Xia N; Zhen Y; Zhang X; Yan N; Guo Q
Front Immunol; 2024; 15():1404828. PubMed ID: 38745647
[TBL] [Abstract][Full Text] [Related]
10. Anti-Ro52 antibodies are associated with the prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease.
Gui X; Shenyun S; Ding H; Wang R; Tong J; Yu M; Zhao T; Ma M; Ding J; Xin X; Qiu Y; Qiu X; Zhang Y; Cao M; Huang M; Cao M; Dai J; Cai H; Xiao Y
Rheumatology (Oxford); 2022 Nov; 61(11):4570-4578. PubMed ID: 35148366
[TBL] [Abstract][Full Text] [Related]
11. Association of anti-nuclear matrix protein 2 antibody with complications in patients with idiopathic inflammatory myopathies: A meta-analysis of 20 cohorts.
Zhong L; Yu Z; Song H
Clin Immunol; 2019 Jan; 198():11-18. PubMed ID: 30445156
[TBL] [Abstract][Full Text] [Related]
12. The significance of myositis autoantibodies in idiopathic inflammatory myopathy concomitant with interstitial lung disease.
Huang HL; Lin WC; Lin PY; Weng MY; Sun YT
Neurol Sci; 2021 Jul; 42(7):2855-2864. PubMed ID: 33211209
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with interstitial lung disease in patients with rheumatoid arthritis: A systematic review and meta-analysis.
Zhang M; Yin J; Zhang X
PLoS One; 2023; 18(6):e0286191. PubMed ID: 37352174
[TBL] [Abstract][Full Text] [Related]
14. Analysis of risk factors of interstitial lung disease and mortality rates in Chinese patients with idiopathic inflammatory myopathy.
Bai Z; Shen G; Dong L
Int J Rheum Dis; 2021 Jun; 24(6):815-827. PubMed ID: 34028988
[TBL] [Abstract][Full Text] [Related]
15. Treatment of idiopathic inflammatory myositis associated interstitial lung disease: A systematic review and meta-analysis.
Barba T; Fort R; Cottin V; Provencher S; Durieu I; Jardel S; Hot A; Reynaud Q; Lega JC
Autoimmun Rev; 2019 Feb; 18(2):113-122. PubMed ID: 30572131
[TBL] [Abstract][Full Text] [Related]
16. Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort.
Chen F; Wang J; Zhang P; Zuo Y; Ye L; Wang G; Shu X
Front Immunol; 2022; 13():879266. PubMed ID: 35603153
[TBL] [Abstract][Full Text] [Related]
17. Tumor markers are associated with rapidly progressive interstitial lung disease in adult-dermatomyositis.
Wang Q; Gao C; Zhang C; Yao M; Liang W; Sun W; Zheng Z
Clin Rheumatol; 2022 Jun; 41(6):1731-1739. PubMed ID: 35138465
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET/CT and HRCT: a combined tool for risk stratification in idiopathic inflammatory myopathy-associated interstitial lung disease.
Zhang Y; Chen Z; Long Y; Zhang B; He Q; Tang K; Zhang X
Clin Rheumatol; 2022 Oct; 41(10):3095-3105. PubMed ID: 35759126
[TBL] [Abstract][Full Text] [Related]
19. Progression prediction in idiopathic inflammatory myopathy-associated interstitial lung disease: a combination of initial high attenuation areas and anti-melanoma differentiation-associated gene 5-positive.
Fang X; Zou L; Zhao H; Liu B
Clin Exp Rheumatol; 2024 Feb; 42(2):253-261. PubMed ID: 38293996
[TBL] [Abstract][Full Text] [Related]
20. hsa-miR-7 Is a Potential Biomarker for Idiopathic Inflammatory Myopathies with Interstitial Lung Disease in Humans.
Yu L; Li J; Chen Y; Jiang J; Fang Q; Jiang J; Wang D; Liu M
Ann Clin Lab Sci; 2018 Nov; 48(6):764-769. PubMed ID: 30610047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
